Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating conjunctivitis and preparation method thereof

A composition and technology for conjunctivitis, applied in the directions of drug combination, pharmaceutical formula, boron compound active ingredient, etc., can solve the problems of visual impairment, easy recurrence, and difficult to cure, and achieve the effects of safe administration, good curative effect and stable preparation.

Inactive Publication Date: 2012-03-14
JILIN AODONG GROUP DALIAN PHARMACEUTICAL CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Conjunctivitis Although conjunctivitis itself generally does not have a serious impact on vision, it can lead to visual impairment when the inflammation spreads to the cornea or causes complications
[0004] At present, there are many western medicines for the treatment of conjunctivitis, but most of them are dedicated to the elimination of superficial symptoms, but it is difficult to remove the root cause of the disease, and long-term use has great side effects on the human body, and it is easy to relapse after a course of treatment, and it is often difficult to cure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011] The following describes a pharmaceutical composition for treating conjunctivitis and a preparation method thereof according to the present invention with reference to the examples.

[0012] A pharmaceutical composition for treating conjunctivitis, comprising 5 parts of pearl powder, 20 parts of chamomile, 15 parts of Mimonella, 20 parts of gentian, 22 parts of cassia seeds, 15 parts of borax, 15 parts of skullcap, and Prunella in the following weight ratios 20 parts, 5 parts musk, 12 parts borneol.

[0013] A method for preparing the above-mentioned pharmaceutical composition for treating conjunctivitis, comprising the following steps: weighing the medicine in the prescription in proportion, adding water and decocting three times for 1 h, 50 min, and 40 min respectively, filtering the decoction, and combining The filtrate was dried at 50 °C, pulverized and passed through a 120-mesh sieve, granulated, and packaged separately.

[0014] The above is only a preferred embod...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating conjunctivitis and a preparation method thereof, wherein the medicine composition for treating conjunctivitis contains the following components in parts by weight: 2-8 parts of pearl powder, 10-40 parts of chamomile, 10-40 parts of felwort, 15-45 parts of semen cassiae, 15-45 parts of borax, 10-40 parts of selfheal spike and 8-30 parts of borneol. The medicine composition for treating conjunctivitis also contains the following components in parts by weight: 10-30 parts of butterflybush flower, 15-45 parts of baical skullcap root and 2-8 parts of musk. The medicine composition for treating conjunctivitis, disclosed by the invention, has the advantages of reasonable formulation, stable preparation, safety in taking and has effects of improving eyesight, relieving pain, diminishing inflammation and relieving itching as well as good curative effect in treating conjunctivitis.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine pharmacy, in particular to a pharmaceutical composition for treating conjunctivitis and a preparation method thereof. Background technique [0002] The conjunctiva is a transparent film covering the inner surface of the eyelid and the white surface of the front of the eyeball. Since most of the conjunctiva is in direct contact with the outside world, it is vulnerable to infectious (such as bacteria, viruses, and chlamydia, etc.) and non-infectious factors in the surrounding environment. (trauma, chemical substances and physical factors, etc.) stimulation, and the conjunctiva is rich in blood vessels and lymphoid tissues, and it is easy to sensitize it to self and external antigens. [0003] Conjunctivitis is an inflammation or infection that occurs in the conjunctiva. Conjunctivitis is a common disease in ophthalmology. Conjunctivitis Although conjunctivitis itself does not generally a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/536A61K36/56A61P27/02A61K35/56A61K35/55A61K33/22A61K31/045A61K35/618
Inventor 刘德胜
Owner JILIN AODONG GROUP DALIAN PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com